Time to Change Guidelines for Laboratory Monitoring During Isotretinoin Treatment

J Cutan Med Surg. 2020 Jan/Feb;24(1):92-93. doi: 10.1177/1203475419879882.

Authors

Danielle Ben-Shoshan¹, Arieh Gomolin², Ivan V Litvinov², Elena Netchiporouk²

Affiliations

¹ 6363 Faculty of Health Sciences, University of Ottawa, ON, Canada.
² 54473 5620 Division of Dermatology, McGill University Health Centre, Montreal, QC, Canada.

PMID: 31994935
DOI: 10.1177/1203475419879882

No abstract available

Keywords: acne vulgaris; hypertriglyceridemia; isotretinoin; laboratory monitoring; leukopenia.

Publication types

Letter
Comment

MeSH terms

Acne Vulgaris* / drug therapy
Dermatologic Agents* / therapeutic use
Humans
Isotretinoin

Substances

Dermatologic Agents
Isotretinoin